White House to announce new drug pricing deals with biotechs, Bloomberg News reports

XBI•2026-08-26

White House plans new drug-pricing agreements with biotechs

Aug. 26 (Reuters) - U.S. President Donald Trump's administration is planning to announce a new round of drug-pricing agreements with midsize biotech companies on Monday, Bloomberg News reported on Wednesday, citing people familiar with the matter.

Reuters could not immediately verify the report.

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

White House plans new drug-pricing agreements with biotechs

Related News

Can US pressure stem cash flows to Iran?

Nasdaq Trade Halt Continues <VMAR.O> Volatility Trading Pause at 12:41 PM

US Midwest refinery utilization rates rise to record in latest week, EIA says

Frontier Nuclear and Minerals holds annual shareholder meeting

U.S. 5-Year Notes High Yield 4.393%